JP2012529451A5 - - Google Patents

Download PDF

Info

Publication number
JP2012529451A5
JP2012529451A5 JP2012514392A JP2012514392A JP2012529451A5 JP 2012529451 A5 JP2012529451 A5 JP 2012529451A5 JP 2012514392 A JP2012514392 A JP 2012514392A JP 2012514392 A JP2012514392 A JP 2012514392A JP 2012529451 A5 JP2012529451 A5 JP 2012529451A5
Authority
JP
Japan
Prior art keywords
solid
composition according
solid composition
fatty acid
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP2012514392A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012529451A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2010/003531 external-priority patent/WO2010142456A1/en
Publication of JP2012529451A publication Critical patent/JP2012529451A/ja
Publication of JP2012529451A5 publication Critical patent/JP2012529451A5/ja
Ceased legal-status Critical Current

Links

JP2012514392A 2009-06-11 2010-06-11 5−アミノレブリン酸を含む固体組成物 Ceased JP2012529451A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP09251538 2009-06-11
EP09251538.6 2009-06-11
PCT/EP2010/003531 WO2010142456A1 (en) 2009-06-11 2010-06-11 Solid compositions comprising 5-aminolevulinic acid

Publications (2)

Publication Number Publication Date
JP2012529451A JP2012529451A (ja) 2012-11-22
JP2012529451A5 true JP2012529451A5 (https=) 2013-08-15

Family

ID=42628133

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012514392A Ceased JP2012529451A (ja) 2009-06-11 2010-06-11 5−アミノレブリン酸を含む固体組成物

Country Status (18)

Country Link
US (1) US20120134921A1 (https=)
EP (1) EP2440188A1 (https=)
JP (1) JP2012529451A (https=)
KR (1) KR20140014401A (https=)
CN (1) CN102802612A (https=)
AU (1) AU2010257752B2 (https=)
BR (1) BRPI1011650A2 (https=)
CA (1) CA2763837A1 (https=)
CL (1) CL2011003115A1 (https=)
CO (1) CO6480960A2 (https=)
CR (1) CR20110649A (https=)
MX (1) MX2011013069A (https=)
NZ (1) NZ596946A (https=)
PE (1) PE20120858A1 (https=)
RU (1) RU2527328C2 (https=)
SG (1) SG176687A1 (https=)
WO (1) WO2010142456A1 (https=)
ZA (1) ZA201108850B (https=)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
DE102012105512A1 (de) * 2012-06-25 2014-04-24 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur verlängerten Freisetzung von Wirkstoffen
US20140067024A1 (en) 2012-08-30 2014-03-06 Photocure Asa Dual panel photodynamic therapy lamp
GB201221123D0 (en) 2012-11-23 2013-01-09 Photocure As Device for photodynamic treatment
AU2014248575A1 (en) * 2013-03-12 2015-10-29 Applied Bioresearch, Inc. Chelation suppository for improved drug delivery
EP3181125B1 (en) * 2014-07-31 2025-02-19 Capsugel Belgium NV Capsule formulation
JP6588193B2 (ja) * 2014-07-31 2019-10-09 カプスゲル・ベルギウム・ナムローゼ・フェンノートシャップCapsugel Belgium NV カプセル製剤
US11623008B2 (en) * 2014-08-20 2023-04-11 Professional Compounding Centers Of America Excipient compositions for mucoadhesive pharmaceutical compositions including a synergistic combination of amylopectin, pullulan, hyaluronic acid, and xyloglucan
US9956426B2 (en) 2015-02-26 2018-05-01 Amol Punjabi Upconverting nanoparticles
BR112018011965A2 (pt) 2015-12-17 2018-12-04 Photocure Asa método de terapia fotodinâmica (pdt) para câncer de bexiga
CN105481946B (zh) * 2015-12-18 2019-05-21 浙江工商大学 5-氨基酮戊酸与3-羟基吡啶-4-酮的缀合物及其制备法和用途
GB201522398D0 (en) 2015-12-18 2016-02-03 Photocure As Device for photodynamic therapy
US10744212B2 (en) * 2016-03-14 2020-08-18 General Electric Company Topical application of nerve labeling dyes for image-guided surgery
GB2546128A (en) * 2016-09-28 2017-07-12 Photocure Asa Pharamaceutical compositions comprising hexaminolevulinic acid and methods of using the same
EP3612570A4 (en) 2017-04-17 2021-01-13 The University of Chicago POLYMERIC MATERIALS FOR THE ADMINISTRATION OF SHORT-CHAIN FATTY ACIDS TO THE INTESTINE FOR HUMAN HEALTH AND DISEASE TREATMENT APPLICATIONS
CN107434753A (zh) * 2017-07-26 2017-12-05 南京大学 5‑氨基乙酰丙酸及其衍生物的泡腾片及其制备方法
US11266619B2 (en) 2017-12-01 2022-03-08 Sbi Pharmaceuticals Co., Ltd. Pharmaceutical composition for enhancing antitumor effect by immune checkpoint inhibitor

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3181062B2 (ja) * 1991-01-31 2001-07-03 帝國製薬株式会社 下部消化管崩壊経口製剤
ATE202076T1 (de) * 1995-03-10 2001-06-15 Photocure Asa Ester der 5-aminolevulinsäure als mittel zur photosensibilisierung in der chemotherapie
US6492420B2 (en) * 1995-03-10 2002-12-10 Photocure As Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy
EP2127642A3 (en) * 1998-08-13 2010-02-24 Cima Labs, Inc. Microemulsions as solid dosage forms for oral administration
CA2376261A1 (en) * 1999-06-09 2000-12-14 Mochida Pharmaceutical Co., Ltd. System for release in lower gastrointestinal tract
DE10003620A1 (de) * 2000-01-28 2001-08-02 Asat Ag Applied Science & Tech 5-Aminolävulinsäure-Formulierung in nichtwässrigen Lösungsmitteln
GB0018527D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Composition
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
US7264629B2 (en) * 2001-11-09 2007-09-04 Qlt, Inc. Photodynamic therapy for the treatment of hair loss
TW577606U (en) * 2001-11-20 2004-02-21 Carry Computer Eng Co Ltd Improved structure of all-in-one silicon disk
DE102005019628A1 (de) * 2005-04-26 2006-11-09 Technische Universität Braunschweig Formulierung zur dermalen Anwendung
GB0609809D0 (en) * 2006-05-17 2006-06-28 Photocure Asa Product
GB0724279D0 (en) * 2007-12-12 2008-01-23 Photocure Asa Use

Similar Documents

Publication Publication Date Title
JP2012529451A5 (https=)
RU2011150920A (ru) Твердые композиции, содержащие 5-аминолевулиновую кислоту
HRP20210686T1 (hr) Pripravci i postupci za liječenje moždanog udara kod subjekta na istodobnoj terapiji statinom
JP2010518029A5 (https=)
JP4415243B2 (ja) 脂肪酸の治療効果の増強作用
JP2021185179A (ja) 固溶体組成物および心血管疾患における使用
JP2015514104A5 (https=)
CN1528315A (zh) 治疗糖皮质素功能失调相关性精神病的方法
ES2525708T3 (es) Derivado de ciclohexano y utilización farmacéutica del mismo
US20260007779A1 (en) Ct contrast agent for detection of cachexia
RU2020101477A (ru) Фармацевтические композиции, содержащие дглк, и их применение
CA3072282A1 (en) Nanoemulsion of iodinated fatty acids for ct imaging
ES2555782T3 (es) Fármaco para prevenir y/o tratar hígado graso o esteatosis hepática no alcohólica
JP2005528414A5 (https=)
JP2020526485A5 (https=)
US9364465B2 (en) Thiazolidinediones of omega-3 polyunsaturated acids as new insulin sensitizers for treating type2 diabetes
US11850252B2 (en) Use of nor-ursodeoxycholic acid for reducing liver fat
CN111093704A (zh) 用于减少身体脂肪的前列环素受体激动剂
AU2023234656A1 (en) Fibrate compositions for treating inflammation and neuroinflammation.
HK40029663A (en) Prostacyclin receptor agonists for reduction of body fat
EA045963B1 (ru) Контрастный агент для кт для детекции кахексии
JPWO2021076847A5 (https=)
US20170327455A1 (en) Omefibrates for Treating Dyslipidemia and Cardiovascular Disease
EP2086585A2 (en) Composition for a pharmaceutical treatment based on triethyl citrate and adapalene